Curaleaf (OTCMKTS:CURLF – Get Free Report) and Akanda (NASDAQ:AKAN – Get Free Report) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.
Insider & Institutional Ownership
0.0% of Curaleaf shares are owned by institutional investors. Comparatively, 1.0% of Akanda shares are owned by institutional investors. 20.4% of Akanda shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Profitability
This table compares Curaleaf and Akanda’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Curaleaf | -18.59% | -14.75% | -5.19% |
Akanda | N/A | N/A | N/A |
Valuation & Earnings
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Curaleaf | $1.35 billion | 1.43 | -$281.20 million | ($0.39) | -7.64 |
Akanda | $2.16 million | 0.12 | -$32.28 million | N/A | N/A |
Akanda has lower revenue, but higher earnings than Curaleaf.
Analyst Ratings
This is a summary of current recommendations for Curaleaf and Akanda, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Curaleaf | 0 | 0 | 1 | 0 | 3.00 |
Akanda | 0 | 0 | 0 | 0 | N/A |
Curaleaf currently has a consensus target price of $6.25, suggesting a potential upside of 109.73%. Given Curaleaf’s higher possible upside, equities research analysts clearly believe Curaleaf is more favorable than Akanda.
Risk and Volatility
Curaleaf has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Akanda has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500.
Summary
Akanda beats Curaleaf on 7 of the 11 factors compared between the two stocks.
About Curaleaf
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.
About Akanda
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.